Tian Huimin, Lyu Yanan, Yang Yong-Guang, Hu Zheng
Key Laboratory of Organ Regeneration & Transplantation of Ministry of Education, The First Hospital of Jilin University, Changchun, China.
National-Local Joint Engineering Laboratory of Animal Models for Human Diseases, Changchun, China.
Front Oncol. 2020 Sep 11;10:1696. doi: 10.3389/fonc.2020.01696. eCollection 2020.
As one of the most popular laboratory animal models, rodents have been playing crucial roles in mechanistic investigations of oncogenesis as well as anticancer drug or regimen discoveries. However, rodent tumors show different or no responses to therapies against human cancers, and thus, in recent years, increased attention has been given to mouse models with xenografted or spontaneous human cancer cells. By combining with the human immune system (HIS) mice, these models have become more sophisticated and robust, enabling exploration of human cancer immunology and immunotherapy. In this review, we summarize the pros and cons of these humanized mouse models, with a focus on their potential as an platform for human cancer research. We also discuss the strategies for further improving these models.
作为最受欢迎的实验动物模型之一,啮齿动物在肿瘤发生机制研究以及抗癌药物或治疗方案的发现中一直发挥着关键作用。然而,啮齿动物肿瘤对人类癌症治疗的反应不同或无反应,因此,近年来,人们越来越关注移植了异种或自发人类癌细胞的小鼠模型。通过与人类免疫系统(HIS)小鼠相结合,这些模型变得更加复杂和强大,能够探索人类癌症免疫学和免疫治疗。在这篇综述中,我们总结了这些人源化小鼠模型的优缺点,重点关注它们作为人类癌症研究平台的潜力。我们还讨论了进一步改进这些模型的策略。